PL
UTHR icon

Parkwood LLC’s United Therapeutics UTHR Stock Holding History

Parkwood LLC’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,627
Closed -$471K – 384
2017
Q2 		$471K Sell
3,627
-388
-10% -$48.4K 0.07% 200
2017
Q1 		$544K Buy
4,015
+746
+23% +$113K 0.08% 174
2016
Q4 		$469K Sell
3,269
-1,721
-34% -$220K 0.07% 194
2016
Q3 		$589K Sell
4,990
-218
-4% -$26.2K 0.09% 166
2016
Q2 		$552K Buy
+5,208
New +$581K 0.09% 192
2015
Q3 		– Sell
-1,200
Closed -$209K – 561
2015
Q2 		$209K Buy
+1,200
New +$216K 0.03% 443

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Parkwood LLC's UTHR Position: Q3 2017 in Review

Parkwood LLC sold out of United Therapeutics (UTHR) in Q3 2017, closing a stake of 3,627 shares — an estimated $471K sold.

Parkwood LLC first reported a position in UTHR in Q2 2015 and held it in 6 quarters. The position peaked at $589K in Q3 2016. 373 funds tracked by Wall St. Rank hold UTHR as of Q3 2017.

  • Parkwood LLC reported no remaining United Therapeutics position as of Q3 2017 after selling out during the quarter.
  • Parkwood LLC sold 3,627 United Therapeutics shares in Q3 2017, an estimated $471K.
  • Parkwood LLC first reported a position in United Therapeutics in Q2 2015 and held it in 6 quarters.
  • Parkwood LLC's United Therapeutics position peaked at $589K in Q3 2016.
  • 373 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2017.

Based on Parkwood LLC's 13F filing for Q3 2017, filed 1 Nov 2017.